CN101940777B - Medicament for treating women pelvic cavity masses - Google Patents

Medicament for treating women pelvic cavity masses Download PDF

Info

Publication number
CN101940777B
CN101940777B CN2010102920895A CN201010292089A CN101940777B CN 101940777 B CN101940777 B CN 101940777B CN 2010102920895 A CN2010102920895 A CN 2010102920895A CN 201010292089 A CN201010292089 A CN 201010292089A CN 101940777 B CN101940777 B CN 101940777B
Authority
CN
China
Prior art keywords
medicament
blood
pelvic cavity
stagnation
blood stasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010102920895A
Other languages
Chinese (zh)
Other versions
CN101940777A (en
Inventor
韩文政
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010102920895A priority Critical patent/CN101940777B/en
Publication of CN101940777A publication Critical patent/CN101940777A/en
Application granted granted Critical
Publication of CN101940777B publication Critical patent/CN101940777B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating women pelvic cavity masses. The medicament is prepared from Chinese medicinal materials such as Chinese angelica, rhubarb, dried ginger, rhizoma corydalis, salvia miltiorrhiza bunge, peach seed, safflower, red paeony root, eupolyphaga and the like. The medicament is prepared by the following steps of: preparing the Chinese medicinal materials according to the conventional preparation method of each Chinese medicinal material; mixing, pulverizing and sieving the Chinese medicinal materials; packing the mixture into capsules No.0, wherein each capsule comprises 0.4 to 0.6 gram of crude medicaments. According to Chinese dialectical therapy, most of the women pelvic cavity masses are concerned with dampness and heat stagnation, cold and dampness stagnation, qi stagnation and blood stasis and viscera function disorder, so the medicament has the effects of invigorating blood circulation and dissipating stagnation, removing blood stasis and stimulating menstrual flow, adjusting liver and tonifying spleen, regulating the normal flow of qi and stopping pain, promoting blood circulation, breaking blood stasis and eliminating women pelvic cavity blood clots. The medicament has the advantages of reasonable formula, convenient administration, good curative effect, no toxic or side effect, elimination of blood stasis and promotion of blood circulation, so diseases are cured by the medicament. According to clinical experiment observation for more than 20 years, the total effective rate of the medicament is 98 percent; the total recovery rate is 98 percent; and no patient relapses during follow-up visit of 5 years.

Description

The medicine of treatment women pelvic lump
Technical field
The present invention relates to a kind of medicine of the women's of treatment pelvic disease, particularly treat the medicine of women's pelvic lump.
Background technology
Women's pelvic lump belongs to the category that the lump in the abdomen leukorrhagia of the traditional Chinese medical science gathers, as adnexitis, salpingitis, endometriosis etc., clinical manifestation is pelvic cavity has bag fast, mostly be acute transformation, major lesions is connective tissue proliferation, form adhesion, juice gathers, and is female internal genital organs and the pelvic peritoneal chronic disease of connective tissue on every side thereof.Main clinical manifestation is: menoxenia, leucorrhoea grow in quantity, waist abdomen pain and infertility etc.As forming chronic adnexitis, then can touch lump, whenever overwork, physical weakness brings out and does, often because of symptom is intricate, and obstinate, the touching stubbornness of the state of an illness is shown effect repeatedly and is influenced healthy, cause suffering to patient, bring unharmonious factor for society and family.According to clinical symptoms, which kind of disease is difficult to sometimes make a definite diagnosis is on earth.
At present which kind of disease the medicine of western medical treatment women pelvic lump is owing to be difficult to make a definite diagnosis sometimes on earth seldom, so when going to see a doctor, can only alleviate clinical symptoms, can't eradicate mostly.Modern medicine mainly contains the Therapeutic Method of primary disease: the one, and anti symptom treatment, but can not effect a radical cure, can only alleviate symptom for the moment; The 2nd, operative treatment, but have a big risk, the expense height, patient is difficult for accepting.
Summary of the invention
The objective of the invention is,, provide a kind of active drug that can thoroughly effect a radical cure women's pelvic lump, to solve the problem that prior art exists according to the tcm treatment according to syndrome differentiation theory.
The diagnosis of women's pelvic lump disease: patient's readme pain in the lumbar region of sleeping evening, sleep a night than doing work in one day and all tire out dizzy cardiopalmus, spiritlessness and weakness, shallow complexion, dark and gloomy; The congestion headache, the numb limbs and tense tendons of sleeping evening; Prolonged low grade fever does not move back, and long-term stomach is bad, controls heavier and heavier by gastropathy; Menalgia has clot.
According to inventor's clinical experience for many years, diagnose this disease not need instrument diagnoses, only need the patient to lie on the back and go down on one's knees, the doctor pushes patient left side lower abdomen with hands, if left lower quadrant has bag fast, does not fixingly move, and pain with tenderness can be diagnosed as women's pelvic lump disease.Umbilicus reaches the right side lower abdomen down has bag not belong to primary disease soon.
Think that according to the tcm treatment according to syndrome differentiation theory women's pelvic lump is more than damp-heat accumulation, cold and stagnate, qi depression to blood stasis, visceral dysfunction is relevant.
Medicament composing prescription of the present invention is: Radix Angelicae Sinensis 30-60 part, Radix Et Rhizoma Rhei 60-90 part, Rhizoma Zingiberis 30-60 part, Rhizoma Corydalis 30-60 part, Radix Salviae Miltiorrhizae 100-150 part, Semen Persicae 60-90 part, Flos Carthami 30-60 part, Radix Paeoniae Rubra 100-150 part, eupolyphaga or Squama Manis 30-60 part.
All medical materials are concocted by the conventional concocting method of each medical material earlier, mix crushing screening by said ratio again, the capsule of packing into No. 0, and every contains crude drug 0.4-0.6g.
The medicinal function of each Chinese medicine medical material of the present invention is:
Radix Angelicae Sinensis, the hot temperature of sweet in the mouth is gone into liver, spleen channel.Function is the promoting the circulation of blood of enriching blood, the pain relieving intestine moistening.
Radix Et Rhizoma Rhei, bitter in the mouth is cold, goes into spleen, stomach, liver, large intestine, the hot relieving constipation of pericardium, the removing blood stasis with potent drugs detoxifcation.
Rhizoma Zingiberis, acrid in the mouth heat is gone into the heart, lung, spleen, stomach warp.Function is a warming middle-JIAO to dispel cold, and recuperating depleted YANG is promoted blood circulation.
Rhizoma Corydalis, Xin Ganwen goes into lung, liver, spleen channel.Function is a blood-activating and qi-promoting, and regulating menstruation relieves the pain.
Radix Salviae Miltiorrhizae, bitter in the mouth is slightly cold, and goes into liver, heart channel.Function is a blood circulation promoting and blood stasis dispelling, and the removing heat from blood detumescence is calmed the nerves.
Semen Persicae, bitter but sweet flavor is flat, goes into the heart, liver, large intestine channel.Function is that removing blood stasis is moisturized, and cures mainly lump in the abdomen.
Flos Carthami, Xin Wen goes into the heart, Liver Channel.Function is a promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing.
Radix Paeoniae Rubra, hardship is slightly cold, and goes into Liver Channel.Function is a promoting blood circulation to restore menstrual flow, the removing heat from blood carbuncle of loosing.
Eupolyphaga, salty, cold, go into Liver Channel, but function is the removing blood stasis removing mass, collateral dredging, reason are hindered.
Squama Manis, salty, be slightly cold, go into liver, stomach warp.Function is a blood circulation promoting and dispersing pathogen accumulation, and eliminating carbuncle is burst hard.
Clinical observation shows that women's pelvic lump is more common in the old man to seventy or eighty years old, and is down to the young married woman in twenty or thirty year, often relevant too early with miscarriage, difficult labour and post partum longtime lochia, men and women's sexual love.Rural area common people also often are called puerperal fever, belong to the stasis of blood disease of motherland's medical science, and stasis of blood disease is meant that blood vessels operations is not smooth, stagnate the various clinical diseases that cohesion or blood circulating out of vessels amass in body to be produced.Motherland's medical science is thought that blood is popular and is obstructed, and disease will take place, as element ask regulating menstruation piece of writing institute cloud " road of the five internal organs, all for channel tunnel with promoting the circulation of blood gas, vim and vigour discord all kinds of diseases and ailments are to change and give birth to ".
Pharmacological action treatment mechanism of the present invention is: the Radix Et Rhizoma Rhei bitter cold, go into spleen, stomach, liver, large intestine channel, and change the relieving constipation that stagnates, just freely then stagnant assigning do not make with gas and hands over resistance, and the capable then blood of gas is capable, and the stagnation of QI is blood stasis then.Xin Wen with Rhizoma Corydalis goes into the blood promoting the circulation of QI to relieve pain, makes the blood promote qi circulation opening, general rule not bitterly, long-pending piece then can dissipate.The Chinese angelica blood supplementing promoting the circulation of blood, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Flos Carthami blood circulation promoting and blood stasis dispelling, promoting blood circulation, stasis-dispelling and pain-killing, and be equipped with eupolyphaga or Squama Manis removing blood stasis with potent drugs, eliminating stagnation, softening the hard mass is with using.Part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels deficiency is easily given birth to endogenous cold, so get the hot warming YANG of Rhizoma Zingiberis to help blood capable.Play circulation of qi promoting altogether, invigorate blood circulation full side, the medicine of blood stasis dispelling, warming middle-JIAO, collateral dredging, pain relieving, removing food stagnancy, softening the hard mass is an one, can make that its stasis of blood is clear, ruton, long-pending piece progressively dissipate, and symptom is alleviated or eliminated.
The good effect of medicine of the present invention is: reasonable recipe, and taking convenience, good effect, through the clinical use of two more than ten years, without any side effects; Have blood circulation promoting and dispersing pathogen accumulation, eliminating blood stasis and inducing menstruation is transferred the liver spleen reinforcing, the effect of regulating QI to relieve pain; Women's pelvic cavity clot is played the effect of promoting the circulation of blood, removing blood stasis with potent drugs, dissipation, reach the capable purpose of stasis of blood blood, all diseases also thereupon more.
The specific embodiment
Embodiment 1: Radix Angelicae Sinensis 5g, Radix Et Rhizoma Rhei 7g, Rhizoma Zingiberis 4g, Rhizoma Corydalis 3g, Radix Salviae Miltiorrhizae 12g, Semen Persicae 9g, Flos Carthami 5g, Radix Paeoniae Rubra 12g, eupolyphaga 5g.
Embodiment 2: Radix Angelicae Sinensis 6g, Radix Et Rhizoma Rhei 8g, Rhizoma Zingiberis 5g, Rhizoma Corydalis 4g, Radix Salviae Miltiorrhizae 15g, Semen Persicae 8g, Flos Carthami 5g, Radix Paeoniae Rubra 15g, Squama Manis 6g.
Above-mentioned Chinese crude drug is concocted respectively with conventional concocting method, the remix crushing screening, the capsule of packing into No. 0, every capsules contains crude drug 0.4-0.6g, every bottle of 120 dresses.
Instructions of taking: each 8, serious symptom every day 2 times, light disease every day gets final product one after each meal 1 time.
Criterion of cure is patient's readme transference cure, pushes left side lower abdomen enclosed mass and disappears, and is painless.
Model case 1: the field, 40 years old, when going to a doctor, the patient says a long tumor in the tripe, taking medicine has an injection does not feel any better, several years, patient's spirit is not good enough, dim complexion, becomes thin the pain in the lumbar region of sleeping evening, fatigue and asthenia, being irritable and getting angry easily, vexed, the abdominal part distension, menstruation shifts to an earlier date, and amount has clot more, is atropurpureus; Deep and hesitant pulse, purplish tongue, touching abdominal part left side pelvic cavity has the piece as hard as flint, fixes and does not move, and according to pressing, the pain of pressing is diagnosed as pelvic lump disease.Give drug oral of the present invention, two bottles are taken effect, eight bottles of recoveries from illness.
Model case 2: Zhao, 75 years old, in year surplus in the of ill 40, according to herself, the medicine administered by injection of annual usefulness was countless, does not all cure her disease.Suffer from for many years old gastrointestinal disease, cardiovascular and cerebrovascular disease, neurasthenia etc. simultaneously, by county hospital diagnosis is slow chronic illness, make referrals to this clinic through others and go to a doctor, by its abdominal part left side, that touches has a lump, fix and do not move, pain with tenderness is diagnosed as pelvic lump disease, gives drug oral of the present invention, two bottles are taken effect, ten bottles of recoveries from illness.
Model case 3: poplar, 42 years old, the patient low grade fever had a surplus January, and is surplus all invalid by flu, inflammation, the viral therapy moon, and body temperature is all the time more than 37 °, and examining its pelvic cavity left side has lump, pain with tenderness.Be diagnosed as pelvic lump disease, give drug oral of the present invention, a bottle temperature is promptly reduced to normally, and other symptom also disappears.
Model case 4: Zhao, 60 years old, patient's readme, midnight every day two, lower limb was unable to explain clearly feels bad from one's late 30s, can't fall asleep, and sat up to have two lower limbs in arms and directly roll about in bed, felt bad to such an extent that directly come to tears sometimes, until the several years.According to the he or she, big infirmary has all seen, and does not all find what reason and causes, what disease also can hardly be explained is, Chinese medicine and western medicine was all used, and medication is countless, and some effects all do not have.Arrive this clinic diagnosis and treatment upon somebody's introduction, examining its lower abdomen left side has lump such as stone, the pain of pressing.Be diagnosed as the pelvic lump syndrome, give drug oral of the present invention, two bottles are taken effect, four bottles of recoveries from illness.
Medicine of the present invention is from 1989-2010, clinical observation treatment 500 examples, and 20-40 year 185 examples, 315 examples more than 40 years old, effective 490 examples, invalid 10 examples are cured 490 examples.Total effective rate 98%, total cure rate 98%.Followed up a case by regular visits to 5 years, and do not have an example recurrence.

Claims (1)

1. medicine for the treatment of women's pelvic lump, the consisting of of its each crude drug: Radix Angelicae Sinensis 30-60 part, Radix Et Rhizoma Rhei 60-90 part, Rhizoma Zingiberis 30-60 part, Rhizoma Corydalis 30-60 part, Radix Salviae Miltiorrhizae 100-150 part, Semen Persicae 60-90 part, Flos Carthami 30-60 part, Radix Paeoniae Rubra 100-150 part, eupolyphaga or Squama Manis 30-60 part.
CN2010102920895A 2010-09-20 2010-09-20 Medicament for treating women pelvic cavity masses Expired - Fee Related CN101940777B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102920895A CN101940777B (en) 2010-09-20 2010-09-20 Medicament for treating women pelvic cavity masses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102920895A CN101940777B (en) 2010-09-20 2010-09-20 Medicament for treating women pelvic cavity masses

Publications (2)

Publication Number Publication Date
CN101940777A CN101940777A (en) 2011-01-12
CN101940777B true CN101940777B (en) 2011-11-16

Family

ID=43433107

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102920895A Expired - Fee Related CN101940777B (en) 2010-09-20 2010-09-20 Medicament for treating women pelvic cavity masses

Country Status (1)

Country Link
CN (1) CN101940777B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102091308B (en) * 2011-01-19 2012-05-23 韩文正 Medicament for treating dysfunctional uterine bleeding
CN104984307A (en) * 2015-08-06 2015-10-21 张翠萍 Chinese herb preparation treating salpingemphraxis and preparing method of Chinese herb preparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1555862A (en) * 2004-01-05 2004-12-22 吴长秀 Chinese medicine for treating palvic infection
CN101780160A (en) * 2010-04-07 2010-07-21 史长山 Traditional Chinese medicine preparation for treating gynecological disease and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1555862A (en) * 2004-01-05 2004-12-22 吴长秀 Chinese medicine for treating palvic infection
CN101780160A (en) * 2010-04-07 2010-07-21 史长山 Traditional Chinese medicine preparation for treating gynecological disease and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘云翔.中医药治疗慢性盆腔炎的进展.《甘肃中医》.1996,第9卷(第3期),46-48. *
刘秀宁.当归元胡汤为主治疗慢性盆腔炎112例观察.《中国中西医结合杂志》.1994,第14卷(第3期),178-179. *
赖冠珍等.慢性盆腔炎中医研究进展.《中医药导报》.2005,第11卷(第11期),76-87. *
黄玉珍.中医药治疗慢性盆腔炎临床研究进展.《浙江中医学院学报》.2001,第25卷(第1期),78-79. *

Also Published As

Publication number Publication date
CN101940777A (en) 2011-01-12

Similar Documents

Publication Publication Date Title
CN101912593B (en) Medicament for treating dysmenorrheal and preparation method thereof
CN101433654B (en) Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof
CN103623358B (en) A kind of Chinese medicine decoction for the treatment of acute, chronic pharyngitis
CN101040927B (en) Chinese traditional medicine compound took orally for treating ankylosing spondylitis
CN102366468A (en) Traditional Chinese medicine for treating vitiligo
CN101036717B (en) Orally taken type Chinese traditional medicine combination for curing irritable bowel syndrome
CN101940777B (en) Medicament for treating women pelvic cavity masses
CN102908582B (en) Traditional Chinese medicine composition for treating blood stasis type abdominal mass for women and preparation method thereof
CN102973677A (en) Traditional Chinese medicine for treating ovarian cyst
CN103083575B (en) Medicine for treating hypertension
CN104906183A (en) Traditional Chinese medicine pill for treating female infertility and preparation method of traditional Chinese medicine pill
CN102579799B (en) Traditional Chinese medicine composition for treating postpartum fever with blood deficiency
CN105902872A (en) Traditional Chinese medicine composition for treating edema
CN104027430A (en) Traditional Chinese medicine composition for treating blood stasis type uterine myoma
CN104043024A (en) Traditional Chinese medicine composition for treating qi depression type abdominal mass
CN103127283A (en) Medicine for treating pelvic inflammation
CN103223046A (en) Traditional Chinese medicine for treating hyperplasia of mammary glands
CN103768214B (en) A kind of Chinese medicine composition for the treatment of kidney yang deficiency syndrome rhinitis
CN102973882A (en) Traditional Chinese medicine for treating cervical spondylosis
CN103263645B (en) Gastritis and gastric ulcer treatment drug
CN102240384B (en) Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof
CN102091163A (en) Chinese medicine composition for treating diabetic heart disease
CN101961459B (en) Oral medicament for treating hemiplegia
CN101618091B (en) Traditional Chinese medicine preparation for treating stony uterine mass, ovarian cyst, sterility and breaks in gynaecology
CN100377739C (en) Gynecopathy treating medicine and its prepn process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111116

Termination date: 20190920

CF01 Termination of patent right due to non-payment of annual fee